Neurological
Nux vomica plant described in Chinese medical texts as early as the 13th century CE; introduced to European medicine circa 16th century; strychnine alkaloid isolated 1818 by Pelletier and Caventou
Strychnine poisoning captured the attention of physicians, toxicologists, and legal authorities for centuries, its dramatic and violent physical manifestations making it one of the most recognizable and feared toxic agents in the historical record. Long before its active compound was chemically isolated, the plant sources from which it derived were known in various cultures as instruments of both medicine and death. The history of strychnine intersected with the development of alkaloid chemistry, forensic toxicology, and the professionalization of poison investigation.
Historical Narrative
The seeds of Strychnos nux-vomica, the tropical tree that served as the primary historical source of strychnine, were documented in Chinese pharmaceutical texts by at least the thirteenth century CE, where they were noted for their bitter taste and powerful physiological effects. Traders carried knowledge of the plant along Indian Ocean and overland routes, and by the sixteenth century European physicians and naturalists had begun to encounter nux vomica as a botanical curiosity and potential medicinal agent. Early modern European herbalists and physicians regarded the seeds with both fascination and caution, acknowledging that small amounts had been used in certain traditions to stimulate appetite and fortify the nervous system while recognizing that larger quantities produced terrifying convulsions and death.
During the seventeenth and eighteenth centuries, the plant's preparations entered European pharmacopoeias, and physicians including followers of the English clinician Thomas Sydenham employed nux vomica preparations in small doses for a variety of ailments, operating under the traditional understanding that almost any substance could be either medicine or poison depending on quantity. The theoretical framework guiding these uses was largely humoral or, by the eighteenth century, increasingly mechanistic, with physicians debating whether nux vomica acted by stimulating vital spirits, exciting the nervous fluid, or increasing the tone of the stomach and intestinal muscles.
The decisive transformation in the scientific understanding of strychnine came in 1818, when French pharmacist-chemists Pierre Joseph Pelletier and Joseph Bienaimé Caventou succeeded in isolating the pure alkaloid from nux vomica seeds. This achievement was part of a broader revolution in chemistry that was yielding the active principles of many plant-derived drugs, and it gave toxicologists and physicians a defined chemical entity to study rather than a crude plant preparation. Pelletier and Caventou's isolation of strychnine represented one of the early triumphs of alkaloid chemistry and set the stage for more precise physiological and toxicological investigation.
The development of forensic toxicology as a scientific discipline ran in parallel with growing concern about strychnine's potential for criminal misuse. The Spanish-French physician Mathieu Orfila, working in Paris in the early nineteenth century, systematically investigated the toxic effects of strychnine in animal experiments and developed methods for detecting it in biological materials, publishing foundational toxicological works that influenced legal medicine across Europe. In Scotland, Robert Christison similarly conducted rigorous experimental and analytical work on poisons including strychnine and testified as an expert in celebrated poisoning trials, helping to establish the model of the medico-legal expert witness that persisted into the twentieth century.
Throughout the nineteenth century strychnine occupied an unusual double position in pharmacological thought, being simultaneously feared as a poison and valued as a stimulant tonic. It appeared in countless proprietary preparations marketed to a general public that associated nervous debility and weakness with a deficiency of stimulation, and its presence in patent medicines became a matter of regulatory concern by the late nineteenth and early twentieth centuries. The gradual withdrawal of strychnine from legitimate medical practice unfolded over decades as pharmacological science developed more refined and reliable agents, though its history continued to be studied as a chapter in the origins of modern neuropharmacology and forensic science.
Key Historical Figures
Historical narrative only — this page describes how Strychnine poisoning was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.